Factors Affecting New-Onset of Restless Legs Syndrome in Pregnancy
Researchers investigated the incidence and risk factors of restless legs syndrome in pregnancy and their relationship to race and ethnicity.
Movement Disorders
GBA Gene Variants in Patients With Parkinson Disease Linked to Motor Decline
Researchers examined longitudinal data from 3 studies of Northern European patients with Parkinson disease and conducted follow-up with 440 patients.
Vitamins E, C Inversely Linked to Risk for Parkinson Disease
Dietary vitamin E and vitamin C intake may be inversely associated with Parkinson disease risk.
Therapies Which Enhance PLCG2 Activity May Be Effective in Treating Parkinson and Alzheimer Diseases
The study authors sought to determine which components of the peripheral immune response correlated with diagnoses of Alzheimer or Parkinson Disease.
Transcranial Magnetic Stimulation Feasible for Functional Limb Weakness
Supramotor threshold transcranial magnetic stimulation to primary motor cortex (M1) is a safe and potentially effective treatment option for functional limb weakness.
Incidence of Restless Leg Syndrome High in Pregnancy
The researchers found that the cumulative incidence of RLS in pregnancy was 18.1 percent for all women and 20.3, 15.4, 17.1, and 21.1 percent for White, Black, Hispanic, and Asian women.
Multi-Strain Probiotic Reduces Constipation in Parkinson Disease
A multi-strain probiotic consisting of 8 different commercially available bacterial strains reduced constipation in patients with Parkinson Disease.
Investigational Drug May Prolong Survival in Patients With ALS
Long-term survival analysis shows that patients with earlier initiation of sodium PB-TURSO treatment for ALS have longer median overall survival.
Prenatal Cannabis Use Associated With Psychopathology in Middle Childhood
A study suggests prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood.
Neurologic Manifestations Seen in Most Hospitalized With COVID-19
Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.
-
Loading...
-
Loading...
Next post in General Neurology
